Cite
Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
MLA
Joyce V. Lee, et al. “Author Correction: Combinatorial Immunotherapies Overcome MYC-Driven Immune Evasion in Triple Negative Breast Cancer.” Nature Communications, vol. 13, Nov. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........55f2a18ae0fdf54c6289af73b312d8d3&authtype=sso&custid=ns315887.
APA
Joyce V. Lee, Filomena Housley, Christina Yau, Rachel Nakagawa, Juliane Winkler, Johanna M. Anttila, Pauliina M. Munne, Mariel Savelius, Kathleen E. Houlahan, Daniel Van de Mark, Golzar Hemmati, Grace A. Hernandez, Yibing Zhang, Susan Samson, Carole Baas, Marleen Kok, Laura J. Esserman, Laura J. van ‘t Veer, Hope S. Rugo, … Andrei Goga. (2022). Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer. Nature Communications, 13.
Chicago
Joyce V. Lee, Filomena Housley, Christina Yau, Rachel Nakagawa, Juliane Winkler, Johanna M. Anttila, Pauliina M. Munne, et al. 2022. “Author Correction: Combinatorial Immunotherapies Overcome MYC-Driven Immune Evasion in Triple Negative Breast Cancer.” Nature Communications 13 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........55f2a18ae0fdf54c6289af73b312d8d3&authtype=sso&custid=ns315887.